COIRO, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 5598
EU - Europa 5280
AS - Asia 2435
Continente sconosciuto - Info sul continente non disponibili 21
SA - Sud America 2
AF - Africa 1
Totale 13337
Nazione #
US - Stati Uniti d'America 5418
CN - Cina 1883
IE - Irlanda 1369
FI - Finlandia 1201
SE - Svezia 916
DE - Germania 728
UA - Ucraina 654
TR - Turchia 486
IT - Italia 223
CA - Canada 180
FR - Francia 53
BE - Belgio 45
GB - Regno Unito 45
IN - India 35
IR - Iran 23
NL - Olanda 23
EU - Europa 21
AT - Austria 10
CY - Cipro 5
LU - Lussemburgo 4
ES - Italia 2
GR - Grecia 2
AL - Albania 1
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
GE - Georgia 1
JP - Giappone 1
MD - Moldavia 1
ME - Montenegro 1
PE - Perù 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 13337
Città #
Chandler 1396
Dublin 1369
Jacksonville 1282
Beijing 555
Izmir 483
Dearborn 441
Nanjing 361
San Mateo 273
Princeton 260
Toronto 171
Ann Arbor 151
Nanchang 139
Des Moines 136
Wilmington 131
Shenyang 123
Kunming 118
Düsseldorf 114
Woodbridge 94
Helsinki 86
Hebei 83
Jinan 63
Hefei 59
Tianjin 53
Grafing 46
Brussels 45
Parma 44
Changsha 41
Leawood 40
Jiaxing 39
Guangzhou 37
Monmouth Junction 24
Augusta 21
Hangzhou 21
Zhengzhou 21
Boardman 19
Bremen 19
Fremont 19
Fuzhou 18
Ardabil 17
Borås 15
Norwalk 15
Ashburn 14
Taiyuan 14
Taizhou 13
Chengdu 11
Haikou 11
Ningbo 11
Rockville 10
Wuhan 10
Lanzhou 9
Mestre 9
Wenzhou 8
Auburn Hills 7
Huizen 7
Miami 7
Baotou 6
Chongqing 6
Mumbai 6
Vienna 6
Xian 6
Sabz 5
Bologna 4
Changchun 4
Fiorenzuola D'arda 4
Luxembourg 4
Bangalore 3
Cagliari 3
Geislingen an der Steige 3
Kocaeli 3
London 3
Los Angeles 3
Philadelphia 3
Redmond 3
Rio Saliceto 3
Seattle 3
Southend 3
Amsterdam 2
Andover 2
Beinasco 2
Chicago 2
Cutrofiano 2
Falls Church 2
Fiumalbo 2
Genova 2
Lodi 2
New Delhi 2
Phoenix 2
Qingdao 2
Rome 2
Shaoxing 2
Ziano Piacentino 2
Abano Terme 1
Alassio 1
Arcevia 1
Ascoli Piceno 1
Atlanta 1
Benevento 1
Bergamo 1
Birmingham 1
Bomporto 1
Totale 8706
Nome #
Effetto del trattamento idropinico con acqua sulfurea della fonte Pergoli di Tabiano nell'epatopatia cronica alcol-correlata 89
Inhibition by somatostatin of LH-RH-induced LH release in normal menstruating women. 89
Inhibitory effect of somatostatin on the NPY response to insulin-induced hypoglycemia and the role of endogenous opioids 85
Effetto coleretico e colagogo dell'acqua sulfureo-solfato calcica di Tabiano sulla colestasi nell'epatopatia alcool-correlata 85
Blunted GH response from cigarette smoking in four week abstinent alcoholics. 76
Luteinizing hormone and cortisol responses to naloxone in normal weight women with bulimia. 76
Different effect of metoclopramide and domperidone on GH release in type 1 male diabetics. 75
Iperresponsività nell'anziano dell'arginin-vasopressina a stimolazione con fumo di sigaretta o con metoclopramide, ma non con ipoglicemia insulinica. 72
Alcoholism abolishes the gamma-aminobutyric acid (GABA)ergic control of GH secretion in humans. 71
Inhibition of growth hormone secretion in mild primary hyperparathyroidism 70
Oxytocin reduces angiotensin II-induced ACTH release in men. 70
Glucagon response to insulin-induced hypoglycemia in obese men. 70
Intravenously infused Substance P is unable to change basal and TRH-stimulated PRL secretion in normal men. 69
Ridotta responsività di ACTH/Cortisolo al naloxone nel Morbo di Parkinson. 69
I fattori regolatori della secrezione di vasopressina. 68
5-HT3 serotonergic receptor mediation of hypoglycemia-induced arginine-vasopressin but not oxytocin secretion in normal men. 68
Oxytocin administration does not alter growth hormone response to insulin induced hypoglycemia in normal men. 68
Iperresponsività nell'anziano dell'arginin-vasopressina a stimolazione con fumo di sigaretta o con metoclopramide, ma non con ipoglicemia insulinica. 68
Growth hormone responses to GHRH, clonidine and insulin-induced hypoglycemia in normal weight bulimic women. 68
TSH and PRL responses to metoclopramide and TRH in normal elderly men. 67
Effect of oxytocin on growth hormone (GH) secretion in response to arginin-vasopressin. 66
Histaminergic H1 and H2 receptors do not mediate cortisol release in response to naloxone in normal men. 66
Effect of muscarinic and nicotinic-cholinergic blockade on the glucagon response to insulin-induced hypoglycemia in normal men. 65
Circadian vairiations in plasma ACTH, cortisol and beta-endorphin levels in normal weight bulimic women. 65
Reduction of lysine vasopressin induced GH, but not ACTH release in elderly men. 65
Alpha2-adrenergic and histamine H1 and H2-receptors do not mediate arginine-vasopressin release in response to insulin induced hypoglycemia in man. 64
5HT1-, but not 5HT2- serotonergic or M1-, M2-muscarinic cholinergic or dopaminergic receptors mediate the ACTH/cortisol response to metoclopramide. 64
Oxytocin does not modify the PRL response to metoclopramide in normal women. 64
Abnormal arginine vasopressin response to cigarette smoking and metoclopramide, but not insulin induced hypoglycemia in elderly subjects. 64
Inhibition by oxytocin of Endothelin-1-induced ACTH secretion in normal men. 63
Alteration in dopaminergic function in abstinent alcoholics. 63
Influenza dell'età sulla responsività ipofisaria GH- e ACTH-secernente alla lisin vasopressina. 63
Thyrotropin-releasing hormone does not inhibit lysine vasopressin-induced growth hormone secretion in normal men. 62
Reduction of nomifensine-induced growth hormone release in elderly men. 62
Lysine-vasopressin inhibits the effect of oxytocin on the insulin response to glucose in normal man. 62
Abnormal arginine vasopressin responses to metoclopramide and insulin induced hypoglycemia in type I diabetes mellitus. 61
Effect of cimetidine on PRL secretion in elderly subjects. 61
Effect of lysine vasopressin on basal and TRH stimulated TSH and PRL release in normal men. 61
TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration. 60
Different effects of Delta-sleep-inducing peptide on arginine-vasopressin and ACTH secretion in normal men. 60
Oxytocin Response to challenging stimuli in elderly men. 60
null 59
Increased Arginine-Vasopressin Response to Hypertonic Stimulation and Upright Posture in Idiopathic Hyperprolactinemia 59
Age-related changed in growth hormone (GH) secretion in normally cycling women. 59
Effect of Naloxone on the LH response to intravenously-infused substance P in normal men 59
Effect of aging on arginine vasopressin response to physiostigmine and angiotensin II in normal men. 59
The gabaergic control of prolactin release is not affected by insulin-dependent diabetes mellitus: evidence from studies with sodium valproate. 59
Effect of serotonergic system on AVP secretion induced by physical exercise 59
Alterazione del controllo oppioide delle gonadotropine, ma non del cortisolo nell'uomo anziano. 59
Lysine-vasopressin does not affect basal and LH-RH stimulated LH and FSH release during the menstrual cycle of normal women. 59
Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycemia in insulin-dependent diabetics. 59
Alterata risposta secretiva del GH allo stimolo GABAergico nel morbo di Parkinson. 59
null 58
Vasopressina, ossitocina ed esercizio fisico 58
GLUCORECEPTORS LOCATED IN THE BRAIN MEDIATE NPY RELEASE INDUCED BY HYPOGLICEMIA IN NORMAL MEN 58
Effect of naloxone on oxytocin-induced cortisol decrease in normal men. 58
Effect of metoclopramide on serum GH levels in normal women. 58
Naloxone decreases the inhibitory effect of somatostatin on GH release induced by cigarette smoking in man 58
Effects of pyridostigmine and naloxone on the abnormal TSH response to TRH during starvation in humans 57
Opioid control of pituitary function in parkinsonian patients before and after dopaminergic therapy 57
ACTH and Beta-Endorphin responses to physical exercise in adolescent women tested for anxiety and frustration 57
The growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics involves a cholinergic mechanism. 57
Stimulatory effect of naloxone on plasma cortical in humans: possible direct stimulatory action at the adrenal cortex. 57
Abnormal plasma oxytocin and b-endorphin levels in alcoholics after short and long-term abstinence. 57
Dopaminergic, but not cholinergic involvement in regulation of hypoglycemia-induced oxytocin release in man. 57
Inhibitory effect of dexamethasone on the oxytocin response to insulin-induced hypoglycemia in normal men. 57
Crenoidrokinesiterapia e supplementazione di vit. D3: un efficace binomio per ridurre il rischio di caduta in donne osteoporotiche con ipovitaminosi D3. 57
Influence of residual C-peptide secretion on the arginine-vasopressin response to hypoglycemia and metergoline in insulin-dependent diabetes. 57
Effect of naloxone on the inhibitory effect of melatonin on the release of arginine-vasopressin induced by physical exercise in man 56
Somatostatin does not modulate arginine vasopressin and oxytocin responses to angiotensin II 56
Effetti sulla tiroide dell'assunzione di iodio in corso di terapia termale a Salsomaggiore 56
Effect of naloxone on neurophysin secretion in normal women. 56
Arginine Vasopressin and Oxytocin responses to angiotensin II are mediated by AT1 receptor subtype in normal men 56
Involvement of nitric oxide in vasoactive intestinal polypeptide-stimulated prolactin secretion in normal men 56
Age-related decreased in the opioid control of LH secretion during reproductive years in normal men. 56
Arginine vasopressin secretion in non obese women with polycystic ovary syndrome. 56
The infusion of somatostatin reduces the arginine vasopressin response to insulin induced hypoglycemia in man. 56
Effetti neuroendocrini della terapia inalatoria con acque salsobromoiodiche di Salsomaggiore. 56
Cholinergic- muscarinic-receptors participate in growth hormone secretion induced by lysine-8-vasopressin in man. 56
La somministrazione endovenosa di ossitocina non determina variazioni nelle concentrazioni di prolattina, TSH e GH in un gruppo di soggetti di sesso maschile. 55
Effect of substance P on basal and TRH-stimulated TSH release in humans 55
Cholinergic mediation of growth hormone secretion induced by thyrotropin-releasing hormone in cirrhotic patients. 55
Different effects of baclofen on LH and cortisol responses to naloxone in normal men. 55
Effect of histaminergic H1- and H2-receptor antagonist on neurophysin release in response to nicotine from cigarette smoking in normal men. 55
Oxytocin response to insulin-induced hypoglycaemia in obese subjects before and after weight loss. 55
Abnormal growth hormone and cortisol but not thyroid stimulating hormone response to an intravenous glucose tolerance test in normal weight bulimic women. 55
Antiserotonergic and antihistaminergic agents do not antagonize naloxone-induced cortisol secretion in normal men. 55
Effect of pharmacological doses of oxytocin on insulin response to glucose in man. 55
Free fatty acids inhibit adrenocorticotropin and cortisol secretion stimulated by physical exercise in normal men. 54
Effect of naloxone on somatostatin inhibition of arginine vasopressin response to physical exercise in normal men 54
Failure of the gamma-aminobutyric acid (GABA) derivative, baclofen, to stimulate growth hormone secretion in Parkinson's disease. 54
Control of oxytocin secretion in elderly men 54
Endogenous opioids modulate the oxytocin response to insulin induced hypoglycaemia and partially mediate the inhibitory effect of ethanol in man. 54
Ruolo degli oppioidi in corso di crisi termale. 54
Influence of residual insulin secretion and duration of diabetes mellitus on the control of LH secretion in women. 54
Naloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercice in man 54
Precoce atrofia cerebrale in alcoolisti di sesso maschile: effetti dell'età e della durata dell'assunzione di alcool e del periodo di astinenza. 54
Reduced sensitivity to pirenzepine-induced blockade of GH responses to arginine, exercise and GHRH in type I diabetic subjects. 54
Graves Disease In Interferon - Treated and Untreated Patients with Chronic Hepatitis C Virus Infection 53
Nicotinic-cholinergic involvement in arginine-vasopressin response to insulin-induced hypoglycemia in normal men. 53
Totale 6118
Categoria #
all - tutte 24332
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24332


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201889 0000 00 00 304388
2018/2019855 311411 8542 1112 572257126
2019/20203555 61068027628 311328 45847 28723837255
2020/20211570 5272346 2540 547 4261247921
2021/20221235 628721 3553 183230 618477450
2022/20234473 490425289355 343545 27306 1693000
Totale 13362